Loss of Olfm4 has been associated with progression of prostate cancer (Chen et al., 2011; Li et al., 2013) and Olfm4 was reported to be a Notch target in intestinal progenitor cells (VanDussen et al., 2012). The gene discussed is OLFM4; the disease is prostate cancer.